Benzinga | Mar 25, 2021 08:46AM EDT

Corvus Pharmaceuticals Q4 EPS $0.92 Up From $(0.38) YoY

Corvus Pharmaceuticals (NASDAQ:CRVS) reported quarterly earnings of $0.92 per share. This is a 342.11 percent increase over losses of $(0.38) per share from the same period last year.